AGREEMENT TO ASSIGN SPACE LEASEAgreement to Assign Space Lease • July 1st, 2022 • Brooklyn ImmunoTherapeutics, Inc. • Pharmaceutical preparations
This AGREEMENT TO ASSIGN SPACE LEASE (the “Agreement”) is made and entered into as of March 5 , 2022 (the “Signature Date”), between these two Delaware limited liability companies: (a) BROOKLYN IMMUNOTHERAPEUTICS LLC (“BITX”); and (b) REGENLAB USA LLC (“Regen”). Terms used in this Agreement may be defined after first usage. An index of defined terms appears on the last page. Certain rights and obligations under this Agreement, as stated in this Agreement, shall become effective only when certain conditions are satisfied and the Assignment Date has occurred.
ASSIGNMENT AND ASSUMPTION OF LEASEAssignment and Assumption of Lease • July 1st, 2022 • Brooklyn ImmunoTherapeutics, Inc. • Pharmaceutical preparations • New York
THIS LEASE AGREEMENT made this 28 day of September, 2015 (the “Effective Date”) between BIOBAT, INC., a Not-for-Profit 50l(c)(3) corporation organized under the laws of the State of New York, having an address c/o SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 129, Brooklyn, New York 11203 (“Landlord”) and IRX THERAPEUTICS, INC., a New York corporation having an address at 140 West 57th Street, Suite 3D, New York, New York (“Tenant”).
